Kannan Soumya, Altae-Tran Han, Zhu Shiyou, Xu Peiyu, Strebinger Daniel, Oshiro Rachel, Faure Guilhem, Moeller Lukas, Pham Julie, Mears Kepler S, Ni Heyuan M, Macrae Rhiannon K, Zhang Feng
Howard Hughes Medical Institute, Cambridge, MA, USA.
Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Nat Biotechnol. 2025 May 7. doi: 10.1038/s41587-025-02655-3.
Naturally existing enzymes have been adapted for a variety of molecular technologies, with enhancements or modifications to the enzymes introduced to improve the desired function; however, it is difficult to engineer variants with enhanced activity while maintaining specificity. Here we engineer the compact Obligate Mobile Element Guided Activity (OMEGA) RNA-guided endonuclease IscB and its guiding RNA (ωRNA) by combining ortholog screening, structure-guided protein domain design and RNA engineering, and deep learning-based structure prediction to generate an improved variant, NovaIscB. We show that the compact NovaIscB achieves up to 40% indel activity (~100-fold improvement over wild-type OgeuIscB) on the human genome with improved specificity relative to existing IscBs. We further show that NovaIscB can be fused with a methyltransferase to create a programmable transcriptional repressor, OMEGAoff, that is compact enough to be packaged in a single adeno-associated virus vector for persistent in vivo gene repression. This study highlights the power of combining natural diversity with protein engineering to design enhanced enzymes for molecular biology applications.
天然存在的酶已被应用于多种分子技术中,人们通过对酶进行增强或修饰来改善其功能;然而,在保持特异性的同时设计出具有增强活性的变体却很困难。在此,我们通过结合直系同源物筛选、结构导向的蛋白质结构域设计和RNA工程,以及基于深度学习的结构预测,对紧凑的专性移动元件引导活性(OMEGA)RNA引导的内切核酸酶IscB及其引导RNA(ωRNA)进行工程改造,以产生一种改进的变体NovaIscB。我们表明,紧凑的NovaIscB在人类基因组上实现了高达40%的插入缺失活性(相对于野生型OgeuIscB提高了约100倍),并且相对于现有的IscB具有更高的特异性。我们进一步表明,NovaIscB可以与甲基转移酶融合,创建一种可编程的转录抑制因子OMEGAoff,其紧凑程度足以包装在单个腺相关病毒载体中,用于体内持续的基因抑制。这项研究突出了将自然多样性与蛋白质工程相结合,为分子生物学应用设计增强型酶的强大作用。